Notice names this product. Amneal Pharmaceuticals of New York’s Exenatide Injection is named in FDA Class II recall D-0868-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Defective Delivery System: Possibility of no medication in the prefilled pen. Identifying details: Lot #: AP250095A, Exp 2/28/2027. Units affected: 5,694 pens. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Defective Delivery System: Possibility of no medication in the prefilled pen.
Company / brand: Amneal Pharmaceuticals of New York recalls
Affected product: Exenatide Injection recall status
Official ID D-0868-2026 · Official record ↗
See all Amneal Pharmaceuticals of New York recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.